Results 301 to 310 of about 280,195 (357)

Polo‐like kinases and UV‐induced skin carcinogenesis: What we know and what's next

Photochemistry and Photobiology, EarlyView.
The polo‐like kinase (PLK) family plays distinct and critical roles in the regulation of cell cycle progression, and its dysregulation has been implicated in various cancers. Ultraviolet (UV) radiation is a well‐established environmental factor in the development of skin cancer.
Tanya Jaiswal, Durdana Muntaqua, Gagan Chhabra, Nihal Ahmad   +3 more
wiley   +1 more source

Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study.

JMIR Res Protoc
Du R, Zhang Y, Yang H, Du Y, Li J, Zhang B.   +5 more
europepmc   +1 more source

Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-up. [PDF]

Blood Adv
Gavrilova T, McIntyre L, Goff SL, Yang JC, Natrakul DA, Rosenberg SA, Kochenderfer JN, Brudno JN.   +7 more
europepmc   +1 more source

Beading wáwya: Counting coup on cancer

The Australian Journal of Anthropology, EarlyView.
Abstract In November of 2022, I was diagnosed with an aggressive form of breast cancer. After 26 years in remission, radiation treatments from my first cancer caused another one. In the months that followed my diagnosis, I gained a greater personal insight into both the medical field—their successes and shortcomings—and the power of creative processes ...
Gretchen Stolte
wiley   +1 more source

Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma. [PDF]

Bone Marrow Transplant
Dong Y, Yang T, Zhao M, Song F, Chen R, Zhang M, Hong R, Feng J, Fu S, Xiao P, Xu H, Cui J, Huang S, Wei G, Chang AH, Huang H, Hu Y.   +16 more
europepmc   +1 more source

Anti Rituximab antibody titer and therapeutic response in Non-Hodgkin Lymphoma Patient Receiving R-Chop Treatment [PDF]

, 2019
Roethmia Yaniari, Ami Ashariati, Siprianus Ugroseno Yudho Bintoro   +2 more
openalex  

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis

Transplant Infectious Disease, EarlyView.
This single‐center retrospective cohort study on 300 allogeneic hematopoietic stem cell transplant recipients from January 2017 to May 2020, in which posaconazole modified release was the most common primary antifungal prophylaxis, demonstrated a breakthrough invasive fungal disease (bIFD) rate of 9%, with associated significant all‐cause mortality at ...
Shio Yen Tio, Chin Fen Neoh, David Ritchie, Lynette Chee, David C. M. Kong, Leon J. Worth, Michelle K. Yong, Monica A. Slavin   +7 more
wiley   +1 more source

IGH/IGK gene rearrangement in the diagnosis of B-cell non-Hodgkin lymphoma: experience from three centers. [PDF]

Ann Hematol
Yang K, Wang Z, Xin B, Li Y, Zhao J, Sun R, Wang W, Chen D, Zhao C, Guo Y, Ma J, Wei B.   +11 more
europepmc   +1 more source

Respiratory Syncytial Virus Exceeded SARS‐CoV‐2 and Influenza in Lower Respiratory Infection and Mortality Rates Among Patients With Hematologic Malignancies During the 2023–2024 Respiratory Virus Season

Transplant Infectious Disease, EarlyView.
During the 2023‐2024 respiratory viral season, respiratory syncytial virus infection was associated with worse outcomes compared to infections caused by SARS‐CoV‐2 and influenza virus in patients with hematologic malignancies ABSTRACT Background Respiratory viral infections (RVIs) significantly impact patients with hematologic malignancies (HMs ...
Tali Shafat, Amy Spallone, Fareed Khawaja, Ying Jiang, Jennifer Jackson, Lior Nesher, Roy F. Chemaly   +6 more
wiley   +1 more source